![]() Illustrates various areas of development where plant bioreactors have made significant advancement in recent times. However, the use of transgenic plants as “BIOREACTORS” is relatively new bioscience and is gaining momentum. After a shift from wild collection to cultivation, advances in plant biotechnology were aimed at direct improvement and modification of specialized constituents of plants like carbohydrates, proteins, oils, fats and vitamins, over a long time period. ![]() Thousands of plant species are used for medicines and most of the world population uses them to cure acute and chronic health problems. Plants have been serving as an extremely valuable source for treatments and therapies, since our existence. A few of these products have already been introduced in the market. A large number of plant-derived recombinant proteins have reached advanced clinical trials. ![]() Various kinds of products that are currently being produced in plants include vaccine antigens, medical diagnostics proteins, industrial and pharmaceutical proteins, nutritional supplements like minerals, vitamins, carbohydrates and biopolymers. Augmenting tissue-specific transcription, elevating transcript stability, tissue-specific targeting, translation optimization and sub-cellular accumulation are some of the strategies employed. As the yield and concentration of a product is crucial for commercial viability, several strategies have been developed to boost up protein expression in transgenic plants. The driving forces behind the rapid growth of plant bioreactors include low production cost, product safety and easy scale up. In recent years, the use of plants as bioreactors has emerged as an exciting area of research and significant advances have created new opportunities.
0 Comments
Leave a Reply. |
AuthorWrite something about yourself. No need to be fancy, just an overview. ArchivesCategories |